In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and ...

An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is the first to demonstrate the isolation and analysis of >99% pure circulating tumor-derived DNA (ctDNA).

Scientists have developed a highly accurate blood test that can detect brain tumours, including aggressive glioblastomas, ...

From endometriosis and cervical cancer, to diabetes, vitamin D deficiency and pollution exposure, scientists are finding ...

Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go ...

Targets $36 Billion TAM in Early Cancer Detection and MRD. Company in active discussions with global diagnostic leaders to accelerate commercialization. HENDERSON, Nev., March 18, ...

RIKEN researchers have demonstrated a method that can detect tiny amounts of biomarkers in liquid samples and can distinguish between highly similar biomarkers. This promises to boost the versatility ...

NeoGenomics' PanTracer™ LBx test has received coverage from the Centers for Medicare & Medicaid Services’ Molecular ...

A man who was told his shoulder pain was due to acid reflux discovered he had incurable blood cancer - after pushing for a second opinion.

University of Edinburgh spin-out BIOCAPTIVA has raised £1.58 million in a new funding round and launched its first product in the US.BIOCAPTIVA’s a novel magnetic bead technology is designed to solve ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Hi, I'm Michelle Lee. I am an oncologist ...